Takeda Pharmaceutical Company Limited announced that the European Commission (EC) granted marketing authorization for AL...
Eisai Co., Ltd. has announced that the latest information on its in-house discovered and developed anticancer agent erib...
Mitsui & Co. ("Mitsui") on November 21, 2018, acquired a stake in GOQii Inc. ("GOQii"), a business providing a preve...
As the world's third largest economy, Japan is leading the way for aging societies. Therefore, the Government ...
Eisai Co., Ltd. announced that the latest data on its antiepileptic drug (AED) perampanel (product name: Fycompa) will b...
Takeda has announced that it has received clearance from the European Commission for the proposed acquisition of Shire a...
Alvotech and Fuji Pharma has announced that the two companies are entering into an exclusive partnership for the commerc...
In a multi-year agreement for up to USD 600 million, Mundipharma has acquired the exclusive rights for Invossa in Japan ...
The Inamori Foundation has announced that it has presented its 34th annual Kyoto Prize in Advanced Technology to Dr. Kar...
HeartFlow, Inc. has announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved the recommenda...
Singapore – Aiming to close its deal for Shire on Jan. 8, Japanese drugmaker, Takeda Pharmaceutical will ...
Royal Philips, a global leader in health technology, has announced a collaboration with Japanese healthcare informatics ...
A research team from Kyoto University, Japan has conducted the world’s first transplant of induced pluripotent ste...
MEI Pharma, Inc. and Kyowa Hakko Kirin Co., Ltd. (KHK), have announced the execution of a license agreement granting KHK...
Hong Kong Science and Technology Parks Corporation (HKSTP) announced its fruitful participation in promoting Hong K...
Japanese drugmaker Kissei Pharmaceutical has acquired exclusive rights to develop and commercialize Tavalisse (fostamati...
Chitin nanofiber is a new material made from crab shells. In brief, it can be prepared by making chitin on a nanoscale. ...
Mitsui Chemicals, Inc. and Chitose Group, a group of biotechnology startups have jointly launched the "0 to 1 Project" a...
